Ironwood Pharmaceuticals, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2008 | — | $-230.4M | $66.3M |
| FY2009 | — | $-298.3M | $122.3M |
| FY2010 | — | $159.6M | $44.3M |
| FY2011 | — | $109.9M | $87.3M |
| FY2012 | — | $144.1M | $136.7M |
| FY2013 | — | $38.2M | $75.5M |
| FY2014 | — | $88.6M | $74.3M |
| FY2015 | $220.6M | $95.1M | $261.3M |
| FY2016 | — | $66.7M | $54.0M |
| FY2017 | — | $9.8M | $125.7M |
| FY2018 | — | $-196.4M | $173.2M |
| FY2019 | — | $-93.3M | $177.0M |
| FY2020 | $430.3M | $62.6M | $362.6M |
| FY2021 | $454.2M | $605.9M | $620.1M |
| FY2022 | $396.3M | $652.4M | $656.2M |
| FY2023 | — | $-346.3M | $92.2M |
| FY2024 | — | $-301.3M | $88.6M |
| FY2025 | — | $-261.8M | $215.5M |